Literature DB >> 20661051

Stillbirth and fetal growth restriction.

Radek Bukowski1.   

Abstract

The association between stillbirth and fetal growth restriction is strong and supported by a large body of evidence and clinically employed for the stillbirth prediction. However, although assessment of fetal growth is a basis of clinical practice, it is not trivial. Essentially, fetal growth is a result of the genetic growth potential of the fetus and placental function. The growth potential is the driving force of fetal growth, whereas the placenta as the sole source of nutrients and oxygen might become the rate limiting element of fetal growth if its function is impaired. Thus, placental dysfunction may prevent the fetus from reaching its full genetically determined growth potential. In this sense fetal growth and its aberration provides an insight into placental function. Fetal growth is a proxy for the test of the effectiveness of placenta, whose function is otherwise obscured during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661051     DOI: 10.1097/GRF.0b013e3181eba0db

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  10 in total

1.  Fetal echocardiography and pulsed-wave Doppler ultrasound in a rabbit model of intrauterine growth restriction.

Authors:  Ryan Hodges; Masayuki Endo; Andre La Gerche; Elisenda Eixarch; Philip DeKoninck; Vessilina Ferferieva; Jan D'hooge; Euan M Wallace; Jan Deprest
Journal:  J Vis Exp       Date:  2013-06-29       Impact factor: 1.355

Review 2.  Cardiotocography and beyond: a review of one-dimensional Doppler ultrasound application in fetal monitoring.

Authors:  Faezeh Marzbanrad; Lisa Stroux; Gari D Clifford
Journal:  Physiol Meas       Date:  2018-08-14       Impact factor: 2.833

3.  A retrospective autopsy study of 42 cases of stillbirth in Avicenna Research Institute.

Authors:  Haleh Soltanghoraee; Maziar Moradi-Lakeh; Narjes Khalili; Azadeh Soltani
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-23       Impact factor: 3.105

4.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

5.  Mid-trimester maternal ADAM12 levels differ according to fetal gender in pregnancies complicated by preeclampsia.

Authors:  Jenny E Myers; Grégoire Thomas; Robin Tuytten; Yven Van Herrewege; Raoul O Djiokep; Claire T Roberts; Louise C Kenny; Nigel A B Simpson; Robyn A North; Philip N Baker
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

Review 6.  Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths.

Authors:  Aamer Imdad; Mohammad Yawar Yakoob; Saad Siddiqui; Zulfiqar Ahmed Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

Review 7.  Predictive factors for intrauterine growth restriction.

Authors:  A R Albu; A F Anca; V V Horhoianu; I A Horhoianu
Journal:  J Med Life       Date:  2014-06-25

Review 8.  Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis.

Authors:  Maria Letizia Urban; Alessandra Bettiol; Irene Mattioli; Alfredo Vannacci; Elena Silvestri; Domenico Prisco; Giacomo Emmi; Gerardo Di Scala; Laura Avagliano; Niccolò Lombardi; Giada Crescioli; Gianni Virgili; Caterina Serena; Federico Mecacci; Claudia Ravaldi
Journal:  Intern Emerg Med       Date:  2021-01-21       Impact factor: 3.397

9.  Bioinformatics Analysis Identifies Potential Related Genes in the Pathogenesis of Intrauterine Fetal Growth Retardation.

Authors:  Chao Xiao; Yao Wang; Yuchao Fan
Journal:  Evol Bioinform Online       Date:  2022-07-28       Impact factor: 2.031

10.  Predicting singleton antepartum stillbirth by the demographic Fetal Medicine Foundation Risk Calculator-A retrospective case-control study.

Authors:  Dana A Muin; Karin Windsperger; Nadia Attia; Herbert Kiss
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.